Summary

The Effect of Anti-Fatigue Decoction on the Behaviors and Serological Indicators in a Central Fatigue Rat Model

Published: April 12, 2024
doi:

Summary

Here, we introduce a protocol to assess the effects of anti-fatigue decoction (AFD) on central fatigue in rats modeled by the modified multiple platform method (MMPM) by monitoring both their behavioral responses and serological markers.

Abstract

This study aimed to assess the effects of Anti-fatigue Decoction (AFD) against central fatigue by observing the behaviors and serological indicators of rats modeled by the modified multiple platform method (MMPM) after drug intervention. Grip strength measurements were used to evaluate the muscle strength of rats. The open field test was utilized to assess anxiety-like behavior, while the Morris water maze test was conducted to evaluate the memory function of the rats. Following the behavioral assessments, rat serum samples were collected to measure the concentrations of corticosterone (CORT) and lactic acid (LAC). The concentration of LAC was determined using the colorimetric method, while the concentration of CORT was measured using the enzyme-linked immunosorbent assay (ELISA) method. Compared to the blank control group, following MMPM modeling, rats exhibited significant reductions in grip strength and impaired ability to memory. The serum analysis revealed increased levels of LAC and CORT in the model group rats. AFD can noticeably reverse these adverse changes to a certain extent. These findings highlight the positive effects of AFD and coenzymeQ10 on physical and cognitive abilities and alterations in serum biomarker levels of central fatigue rats.

Introduction

Fatigue is a multifaceted and non-specific phenomenon that is typically characterized by feelings of tiredness and reduced ability to function1. It can be classified as either peripheral fatigue, which occurs at the muscular level, or central fatigue, originating in the central nervous system3,4. Prolonged central fatigue can be a significant contributor to psychological issues, including anxiety, depression, psychological distress, and memory problems5,6. Despite causing significant distress, there is a scarcity of specific medications targeting central fatigue7. While methylphenidate, a central nervous system stimulant, can provide temporary relief, its side effects, like insomnia and palpitations may worsen the condition8,9.

In previous clinical applications, traditional Chinese medicine has shown promising results in treating central fatigue, incorporating approaches such as oral decoctions, acupuncture, and Tai Chi10,11,12. Anti-fatigue decoction (AFD) is an effective formula developed by Professor Li Feng based on extensive clinical experience and has demonstrated positive therapeutic effects. It consists of Astragalus membranaceus (Huangqi), Fructus aurantii (Zhiqiao), Fructus crataegi (Shanzha), Schisandra chinensis (Wuweizi), Angelica sinensis (Danggui), and Dendrobium officinale (Shihu), in a ratio of 15: 15: 10: 5: 7: 8. AFD decoction was concentrated to 110 mL after boiling with ten times the volume of deionized water for 1 h thrice. In a previous study, we established an animal model of central fatigue using the Modified Multiple Platform Method (MMPM) and confirmed the manifestation of central fatigue via behavioral and central nervous system neurotransmitter evaluations13. In this study, we utilized the AFD intervention in the animal model of central fatigue to evaluate its pharmacological effects through behavioral assessments.

Protocol

This research work adheres to ethical guidelines for animal welfare. Proper care and housing conditions were maintained to ensure the health and well-being of the animals, and all procedures were approved by the institutional animal care and use committee of the Beijing University of Chinese Medicine (BUCM-4-2019041504-2094). 1. Animal raising and grouping NOTE: Throughout the study, animal welfare was maintained following the 3Rs (Reduction, Refineme…

Representative Results

Compared to the control group, the rats in the model group exhibited significant decreases in grip strength. However, the administration of AFD at low, medium, and high doses was all able to reverse this effect in a dose-dependent manner, as shown in Figure 1. Similarly, the positive control drug also demonstrated the ability to reverse the grip strength changes (Figure 1). In the open field test, the model group rats showed reduction…

Discussion

AFD is composed of Astragalus membranaceus (Huangqi), Fructus aurantii (Zhiqiao), Fructus crataegi (Shanzha), Schisandra chinensis (Wuweizi), Angelica sinensis (Danggui), and Dendrobium officinale (Shihu), which is believed to have the function of invigorating the spleen and dispersing the stagnated liver-energy in traditional Chinese medicine. Also, all these herbs are considered to possess a favorable safety profile and are thus commonly used as food in China. In pr…

Divulgazioni

The authors have nothing to disclose.

Acknowledgements

All authors would like to express their gratitude for the support from the National Natural Science Foundation of China (NO. 81874428) and Research project of Beijing University of Traditional Chinese Medicine (NO.2023-JYB-JBZD-001).

Materials

Corticosterone test kit German DRG company EIA4164 Step 4.3
Curve Expert 1.4 software CurveExpert Professional Version 1.4 For calculation in corticosterone assay
Ethovision software  Noldus Information Technology , Netherlands Version 15 analysis software and video tracking system
Grip strength test device Beijing Zhongshi Di Chuang limited company ZS-ZL Step 3.1
Lactic acid test kit Nanjing Jiancheng Bioengineering Research Institute A019-2-1 Step 4.2
Modified multiple platform method Neuroimmunology Laboratory of Beijing University of Chinese Medicine None Step 2.1
Morris water maze test device Beijing Zhongshi Di Chuang limited company ZS-Morris Step 3.3
Open field test device Beijing Zhongshi Di Chuang limited company ZS-KC Step 3.2
Prism GraphPad  Verson 8 For generating figures
SPSS 26.0 IBM Verson 26.0 Statistical analysis 
Wistar rats  SiPeiFu (Beijing) Biotechnology Co., Ltd license number: SCXK (Jing) 2019-0010

Riferimenti

  1. Dukes, J. C., Chakan, M., Mills, A., Marcaurd, M. Approach to fatigue: Best practice. Med Clin North Am. 105 (1), 137-148 (2021).
  2. Zargari Marandi, R., Madeleine, P., Omland, &. #. 2. 1. 6. ;., Vuillerme, N., Samani, A. Eye movement characteristics reflected fatigue development in both young and elderly individuals. Sci Rep. 8 (1), 13148 (2018).
  3. Tornero-Aguilera, J. F., Jimenez-Morcillo, J., Rubio-Zarapuz, A., Clemente-Suárez, V. J. Central and peripheral fatigue in physical exercise explained: A narrative review. Int J Environ Res Public Health. 19 (7), 3909 (2022).
  4. Dotan, R., Woods, S., Contessa, P. On the reliability and validity of central fatigue determination. Eur J Appl Physiol. 121 (9), 2393-2411 (2021).
  5. AlSaeed, S., et al. Fatigue, depression, and anxiety among ambulating multiple sclerosis patients. Front Immunol. 13, 844461 (2022).
  6. Lee, C. H., Giuliani, F. The role of inflammation in depression and fatigue. Front Immunol. 10, 1696 (2019).
  7. Meeusen, R., Watson, P., Hasegawa, H., Roelands, B., Piacentini, M. F. Central fatigue: the serotonin hypothesis and beyond. Sports Med. 36 (10), 881-909 (2006).
  8. Nourbakhsh, B., et al. Safety and efficacy of amantadine, modafinil, and methylphenidate for fatigue in multiple sclerosis: a randomised, placebo-controlled, crossover, double-blind trial. Lancet Neurol. 20 (1), 38-48 (2021).
  9. Rojí, R., Centeno, C. The use of methylphenidate to relieve fatigue. Curr Opin Support Palliat Care. 11 (4), 299-305 (2017).
  10. Luo, C., et al. Natural medicines for the treatment of fatigue: Bioactive components, pharmacology, and mechanisms. Pharmacol Res. 148, 104409 (2019).
  11. Wang, T., Xu, C., Pan, K., Xiong, H. Acupuncture and moxibustion for chronic fatigue syndrome in traditional Chinese medicine: a systematic review and meta-analysis. BMC Complement Altern Med. 17 (1), 163 (2017).
  12. Xiang, Y., Lu, L., Chen, X., Wen, Z. Does Tai Chi relieve fatigue? A systematic review and meta-analysis of randomized controlled trials. PLoS One. 12 (4), e0174872 (2017).
  13. Zhang, W., et al. A rat model of central fatigue using a modified multiple platform method. J Vis Exp. (138), e57362 (2018).
  14. Drug Ther Bull. Body surface area for adjustment of drug dose. Drug Ther Bull. 48 (3), 33-36 (2010).
  15. Harrison, E. L., Baune, B. T. Modulation of early stress-induced neurobiological changes: a review of behavioural and pharmacological interventions in animal models. Transl Psychiatry. 4 (5), e390 (2014).
  16. Sanoobar, M., Dehghan, P., Khalili, M., Azimi, A., Seifar, F. Coenzyme Q10 as a treatment for fatigue and depression in multiple sclerosis patients: A double blind randomized clinical trial. Nutr Neurosci. 19 (3), 138-143 (2016).
  17. Grace, P. M., et al. Behavioral assessment of neuropathic pain, fatigue, and anxiety in experimental autoimmune encephalomyelitis (EAE) and attenuation by interleukin-10 gene therapy. Brain Behav Immun. 59, 49-54 (2017).
  18. Kraeuter, A. K., Guest, P. C., Sarnyai, Z. The open field test for measuring locomotor activity and anxiety-like behavior. Methods Mol Biol. 1916, 99-103 (2019).
  19. Jin, Q., et al. Network and experimental pharmacology to decode the action of wendan decoction against generalized anxiety disorder. Drug Des Devel Ther. 16, 3297-3314 (2022).
  20. Othman, M. Z., Hassan, Z., Che Has, A. T. Morris water maze: a versatile and pertinent tool for assessing spatial learning and memory. Exp Anim. 71 (3), 264-280 (2022).
  21. Bromley-Brits, K., Deng, Y., Song, W. Morris water maze test for learning and memory deficits in Alzheimer’s disease model mice. J Vis Exp. (53), e2920 (2011).
  22. Richardson, A. E., VanderKaay Tomasulo, M. M. Stress-induced HPA activation in virtual navigation and spatial attention performance. BMC Neurosci. 23 (1), 40 (2022).
  23. Mikulska, J., Juszczyk, G., Gawrońska-Grzywacz, M., Herbet, M. HPA axis in the pathomechanism of depression and schizophrenia: New therapeutic strategies based on its participation. Brain Sci. 11 (10), 1298 (2021).
  24. Passos, G. S. Insomnia severity is associated with morning cortisol and psychological health. Sleep Sci. 16 (1), 92-96 (2023).
  25. Herane-Vives, A., et al. Cortisol levels in chronic fatigue syndrome and atypical depression measured using hair and saliva specimens. J Affect Disord. 267, 307-314 (2020).
  26. Kang, J. Y., et al. Korean red ginseng ameliorates fatigue via modulation of 5-HT and corticosterone in a sleep-deprived mouse model. Nutrients. 13 (9), 3121 (2021).
  27. Rabinowitz, J. D., Enerbäck, S. Lactate: the ugly duckling of energy metabolism. Nat Metab. 2 (7), 566-571 (2020).
  28. Proia, P., Di Liegro, C. M., Schiera, G., Fricano, A., Di Liegro, I. Lactate as a metabolite and a regulator in the central nervous system. Int J Mol Sci. 17 (9), 1450 (2016).
  29. Zu, Y., Lu, X., Yu, Q., Yu, L., Li, H., Wang, S. Higher postdialysis lactic acid is associated with postdialysis fatigue in maintenance of hemodialysis patients. Blood Purif. 49 (5), 535-541 (2020).
This article has been published
Video Coming Soon
Keep me updated:

.

Citazione di questo articolo
Li, J., Liu, Y., Li, R., Liu, Y., Li, F. The Effect of Anti-Fatigue Decoction on the Behaviors and Serological Indicators in a Central Fatigue Rat Model. J. Vis. Exp. (206), e66481, doi:10.3791/66481 (2024).

View Video